US-based home and alternate treatment site infusion services provider Option Care Enterprises has launched its new Care Management Center (CMC) in Atlanta.
The CMC is designed to offer clinical care to nearly 1,000 patients that require infusion therapies for anti-infectives, clinical nutrition support, immunoglobulin therapy and conditions such as chronic inflammatory disorders and bleeding disorders.
The new centre provides support through its full-service infusion pharmacy and clinical management of patients, AIS and patient registration assistance.
The AIS at the Atlanta CMC location is equipped with three infusion chairs in private rooms. Personalised treatments will be provided by nurses who are trained in infusion therapy.
Option Care chief executive officer John Rademacher said: “This new CMC is the very best of everything Option Care offers to patients. We know these critical therapies make it possible for patients to enjoy vitality and quality of life and we’re thrilled to be able to deliver that to more patients in the Atlanta area.
“This new CMC is a representation of our commitment to providing exceptional clinical care through the best clinicians and facilities available.”
According to the company, the CMC will be further equipped with Option Care’s updated technology-enabled, data-driven services and programmes to provide superior clinical care.
With over 40 years of experience in the field of clinical care experience, Option Care has a multidisciplinary team of more than 1,700 clinicians.
In March this year, BioScrip entered into a definitive merger agreement with Option Care. The transaction is expected to complete in the second half of this year.